NavGeneral InfoEmail Print Provider JMI Laboratories (United States) Geography Argentina (ARG) Austria (AUT) Belarus (BLR) Belgium (BEL) Brazil (BRA) Bulgaria (BGR) Chile (CHL) Colombia (COL) Costa Rica (CRI) Croatia (HRV) Czechia (CZE) Democratic People's Republic of Korea (PRK) Denmark (DNK) Ecuador (ECU) Finland (FIN) France (FRA) Germany (DEU) Greece (GRC) Guatemala (GTM) Hungary (HUN) Ireland (IRL) Israel (ISR) Italy (ITA) Japan (JPN) Malaysia (MYS) Mexico (MEX) Netherlands (NLD) Norway (NOR) Panama (PAN) Peru (PER) Philippines (PHL) Poland (POL) Portugal (PRT) Republic of Korea (KOR) Romania (ROU) Russian Federation (RUS) Singapore (SGP) Slovakia (SVK) Slovenia (SVN) Spain (ESP) Sweden (SWE) Switzerland (CHE) Taiwan (Province of China) (TWN) Thailand (THA) Türkiye (TUR) Ukraine (UKR) United Kingdom (GBR) United States of America (USA) Venezuela (Bolivarian Republic of) (VEN) Viet Nam (VNM) View all Coverage type Global Time period covered 01/2012 - 12/2018 Data type Epi surveillance: Epi surveillanceHealth facility Keywords Bacterial skin diseases, Drug resistance, Lower respiratory infections, Medical tests, Prevalence, Urinary tract infections Citation Contributors JMI Laboratories (United States) Funders JMI Laboratories (United States) Suggested citation JMI Laboratories (United States). SENTRY Antimicrobial Surveillance Program Data 2012-2018. GHDx Entry last modified on: Sep 17, 2024